Vaxcyte
NASDAQ: PCVX6 known investors
Vaxcyte develops broad-spectrum vaccines to prevent bacterial infections, using a cell-free protein synthesis platform and synthetic chemistry techniques. Its pipeline includes pneumococcal conjugate vaccines (VAX-31 and VAX-24) and early-stage candidates targeting Group A Strep and Shigella.
BiotechHealthtech
Investors · 6
Competitors · 3
by search overlapAnacor47 shared keywordsPfizer is a pharmaceutical company that researches, develops, and manufactures medicines and treatments across a range of diseases. It also runs patient assistance programs and global health initiatives to broaden access to its products.
Dynavax NASDAQ: DVAX www.dynavax.com43 shared keywordsDynavax is a biopharmaceutical company that develops and commercializes vaccines to protect against infectious diseases, including HEPLISAV-B, a two-dose adult hepatitis B vaccine, and its CpG 1018 adjuvant used in multiple vaccines. The company also advances a pipeline of novel vaccine clinical candidates.
Vaccinex40 shared keywordsVaccinex is a clinical-stage biotechnology company developing pepinemab (VX15/2503), a humanized monoclonal antibody that blocks SEMA4D signaling, in trials for neurological disorders such as Huntington's and Alzheimer's disease and for solid tumors including breast cancer, melanoma, non-small cell lung cancer and head and neck cancer. It also offers a fusion protein and ActivMab antibody discovery technology for incorporating membrane proteins such as GPCRs and ion channels into poxviruses for antibody selection.
Companies competing with Vaxcyte for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vaxcyte do?
- Vaxcyte develops broad-spectrum vaccines to prevent bacterial infections, using a cell-free protein synthesis platform and synthetic chemistry techniques. Its pipeline includes pneumococcal conjugate vaccines (VAX-31 and VAX-24) and early-stage candidates targeting Group A Strep and Shigella.
- Who are Vaxcyte's investors?
- Vaxcyte's investors include BioRock Ventures, CTI Life Sciences Fund L.P., Foresite Capital, Frazier Life Sciences, Longitude Capital, RA Capital.